PROTEINA Co., Ltd.

As of June 30, 2026, PROTEINA Co., Ltd. carries a market capitalization of 309.04B, placing it among publicly traded companies globally. Its enterprise value stands at 290.39B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, PROTEINA Co., Ltd. has 10.94M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 211.57, and the price-to-book ratio stands at 13.62.

These figures are as of June 30, 2026. The EV/Sales ratio of 201.19 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 290.39B versus a market cap of 309.04B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, PROTEINA Co., Ltd. maintains a current ratio of 11.25, meaning it holds 11.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 3.21, indicating elevated leverage, while an interest coverage ratio of -141.93 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, PROTEINA Co., Ltd. posted a negative return on equity (ROE) of -68.13, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -57.43, reflecting losses generated across the asset base. Inventory turnover of 2.27 indicates how many times PROTEINA Co., Ltd. sells and replaces its inventory over a year, a key working capital efficiency ratio.

As of the close on October 23, 2026, PROTEINA Co., Ltd.'s stock has declined approximately 8.62% over the past 52 weeks. The 50-day moving average sits at 37,701.00, while the 200-day moving average is 52,460.60.

Over the twelve months ended June 30, 2026, PROTEINA Co., Ltd. generated 1.44B in revenue and converted that into -12.00B in net income, yielding earnings per share of -1,110.15. EBITDA reached -14.66B, while operating income came in at -16.06B.

As of June 30, 2026, PROTEINA Co., Ltd. holds 19.38B in cash and equivalents against 727.98M in total debt, resulting in a net debt position of -2.09B. Total book value stands at 22.69B, with working capital of 19.73B providing operational flexibility.

PROTEINA Co., Ltd. produced -10.30B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -1.86B in capital expenditures, free cash flow totaled -12.16B - equivalent to -1,124.59 per share.

Over the twelve months ended June 30, 2026, PROTEINA Co., Ltd. posted a gross margin of 42.91, reflecting its pricing power and cost economics. The operating margin of -1,112.94 and net profit margin of -831.41 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -3.98: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -6.96, meaning PROTEINA Co., Ltd. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, PROTEINA Co., Ltd. has an Altman Z-Score of 43.83, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.